MAP4K4-IN-3 (Compound 17) is a potent and selective MAP4K4 inhibitor with an IC50 of 14.9 nM in kinase assay, an IC50 of 470 nM in cell assay. Antidiabetic agent[1].
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | MAP4K4-IN-3 serves as a potent, selective inhibitor of MAP4K4, demonstrating an IC50 value of 14.9 nM in kinase assays and 470 nM in cellular assays. It is noted for its antidiabetic properties[1]. |
体内研究 | Oral administration of MAP4K4-IN-3 (25 mg/kg, b.iD.) to telemetered rats for 5 days, leads to multiple adverse reactions. Significant reductions in weight (7%) and increments in body temperature (0.4°C) compared to controls were noted during the study period. Regarding cardiovascular parameters, a peak increase in heart rate by 25 bpm, in comparison to controls, was triggered by the MAP4K4-IN-3 treatment[2]. |
体外研究 | MAP4K4, identified as a serine/threonine protein kinase, presents a potential target for antidiabetic drugs[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.36mL 0.67mL 0.34mL |
16.79mL 3.36mL 1.68mL |
33.59mL 6.72mL 3.36mL |
CAS号 | 1811510-58-3 |
分子式 | C15H12ClN5 |
分子量 | 297.742 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Inert atmosphere,2-8°C |
溶解度 |
DMSO: 9 mg/mL(30.23 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |